122 related articles for article (PubMed ID: 10806806)
1. Clinical study of multi-drug resistance gene (MDR1) expression in primary ovarian cancer.
Wang S; Cai G
J Tongji Med Univ; 1998; 18(1):58-60. PubMed ID: 10806806
[TBL] [Abstract][Full Text] [Related]
2. [Clinical correlations of multidrug resistance gene expression in ovarian carcinoma].
Chen X; Li L; Huang W
Zhonghua Fu Chan Ke Za Zhi; 1996 Nov; 31(11):652-5. PubMed ID: 9387523
[TBL] [Abstract][Full Text] [Related]
3. Clinical correlates of MDR1 (P-glycoprotein) gene expression in ovarian and small-cell lung carcinomas.
Holzmayer TA; Hilsenbeck S; Von Hoff DD; Roninson IB
J Natl Cancer Inst; 1992 Oct; 84(19):1486-91. PubMed ID: 1359152
[TBL] [Abstract][Full Text] [Related]
4. [Study on multidrug resistant gene (MDR1) expression between neoplastic cells and peripheral blood lymphocytes in ovarian carcinoma].
Yin G; Chen S; Sun X
Zhonghua Fu Chan Ke Za Zhi; 1998 May; 33(5):287-9. PubMed ID: 10682441
[TBL] [Abstract][Full Text] [Related]
5. [The expression of multiple drug resistance associated genes in ovarian cancer].
Cheng G; Zhu H; Sun L
Zhonghua Fu Chan Ke Za Zhi; 2000 Feb; 35(2):87-90. PubMed ID: 11809106
[TBL] [Abstract][Full Text] [Related]
6. [A quantitative study on nuclear DNA content and morphological parameters in ovarian cystadenocarcinoma].
Liu C; Zhao Y; Sun X
Zhonghua Fu Chan Ke Za Zhi; 1995 Dec; 30(12):738-40. PubMed ID: 8728920
[TBL] [Abstract][Full Text] [Related]
7. Expression of MDR1 in epithelial ovarian cancer and its association with disease progression.
Lu L; Katsaros D; Wiley A; Rigault de la Longrais IA; Puopolo M; Yu H
Oncol Res; 2007; 16(8):395-403. PubMed ID: 17913048
[TBL] [Abstract][Full Text] [Related]
8. Clinical relationship between MDR1 gene and gallbladder cancer.
Wang BL; Zhai HY; Chen BY; Zhai SP; Yang HY; Chen XP; Zhao WT; Meng L
Hepatobiliary Pancreat Dis Int; 2004 May; 3(2):296-9. PubMed ID: 15138130
[TBL] [Abstract][Full Text] [Related]
9. [The relationship between multi-drug resistance gene expression and drug resistance of ovarian carcinoma].
Zhu L; Lang J; Shen K
Zhonghua Fu Chan Ke Za Zhi; 1997 Aug; 32(8):462-6. PubMed ID: 9639738
[TBL] [Abstract][Full Text] [Related]
10. [Expression of mesothelin mRNA and protein in ovarian carcinomas].
Bi SN; Dai SZ; Yao Q; Che YC; Wang N
Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):288-91. PubMed ID: 18788634
[TBL] [Abstract][Full Text] [Related]
11. ATP-binding cassette superfamily transporter gene expression in human primary ovarian carcinoma.
Ohishi Y; Oda Y; Uchiumi T; Kobayashi H; Hirakawa T; Miyamoto S; Kinukawa N; Nakano H; Kuwano M; Tsuneyoshi M
Clin Cancer Res; 2002 Dec; 8(12):3767-75. PubMed ID: 12473588
[TBL] [Abstract][Full Text] [Related]
12. RNA expression of MDR1/P-glycoprotein, DNA-topoisomerase I, and MRP2 in ovarian carcinoma patients: correlation with chemotherapeutic response.
Materna V; Pleger J; Hoffmann U; Lage H
Gynecol Oncol; 2004 Jul; 94(1):152-60. PubMed ID: 15262134
[TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor isoform gene expression in ovarian stromal and epithelial tumors.
Chu S; Mamers P; Burger HG; Fuller PJ
J Clin Endocrinol Metab; 2000 Mar; 85(3):1200-5. PubMed ID: 10720062
[TBL] [Abstract][Full Text] [Related]
14. [Correlation of expression levels of multidrug resistance gene 1 (mdr1) mRNA, multidrug resistance-associated protein (MRP), amd P-glycoprotein (P-gp) with chemotherapy efficacy in malignant lymphomas].
Yang X; Jia L; Wei L; Zuo W; Song S
Zhonghua Yi Xue Za Zhi; 2002 Sep; 82(17):1177-9. PubMed ID: 12475404
[TBL] [Abstract][Full Text] [Related]
15. [Study on the expression of the gene deleted in colorectal carcinoma in ovarian carcinoma].
Li PL; Liu MM; Ni J
Zhonghua Fu Chan Ke Za Zhi; 2003 Apr; 38(4):207-9. PubMed ID: 12885365
[TBL] [Abstract][Full Text] [Related]
16. Clinical relevance of multidrug resistance gene expression in ovarian serous carcinoma effusions.
Gillet JP; Wang J; Calcagno AM; Green LJ; Varma S; Bunkholt Elstrand M; Trope CG; Ambudkar SV; Davidson B; Gottesman MM
Mol Pharm; 2011 Dec; 8(6):2080-8. PubMed ID: 21761824
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs.
Chen S; Jiao JW; Sun KX; Zong ZH; Zhao Y
Drug Des Devel Ther; 2015; 9():5225-35. PubMed ID: 26396496
[TBL] [Abstract][Full Text] [Related]
18. Expression of gonadotropin-releasing hormone receptor in human epithelial ovarian carcinoma.
Imai A; Ohno T; Ohsuye K; Tamaya T
Ann Clin Biochem; 1994 Nov; 31 ( Pt 6)():550-5. PubMed ID: 7880073
[TBL] [Abstract][Full Text] [Related]
19. Expression of multidrug resistance gene and localization of P-glycoprotein in human primary ovarian cancer.
Arao S; Suwa H; Mandai M; Tashiro H; Miyazaki K; Okamura H; Nomura H; Hiai H; Fukumoto M
Cancer Res; 1994 Mar; 54(5):1355-9. PubMed ID: 7509719
[TBL] [Abstract][Full Text] [Related]
20. mdr1 mRNA expression by RT-PCR in patients with primary breast cancer submitted to neoadjuvant therapy.
Wang CS; LaRue H; Fortin A; Gariépy G; Têtu B
Breast Cancer Res Treat; 1997 Aug; 45(1):63-74. PubMed ID: 9285118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]